Tamoxifen alters the localization of f-actin and α5/β1-lntegrin fibronectin receptors in human endometrial stromal cells and carcinoma cells

Pathobiology

Volumn 65, Issue 4, 1997, Pages 177-183

  Albright, Craig D ^a   Carter, Charleata A ^b   Kaufman, David G ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Cytoskeleton; Endometrium; F actin; Integrin receptors; Tamoxifen

Indexed keywords

F ACTIN; FIBRONECTIN RECEPTOR; FLUORESCEIN; INTEGRIN; N (2 GUANIDINOETHYL) 5 ISOQUINOLINESULFONAMIDE; PHALLOIDIN; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; STAUROSPORINE; TAMOXIFEN;

ACTIN FILAMENT; ARTICLE; CAPPING PHENOMENON; CELL MEMBRANE; CELL ULTRASTRUCTURE; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOSKELETON; ENDOMETRIUM; ENDOMETRIUM CARCINOMA; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; STROMA CELL;

ACTINS; ADENOCARCINOMA; CELLS, CULTURED; ENDOMETRIAL NEOPLASMS; ENZYME INHIBITORS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; ISOQUINOLINES; MICROSCOPY, CONFOCAL; PROTEIN KINASE INHIBITORS; RECEPTORS, FIBRONECTIN; STAUROSPORINE; STROMAL CELLS; SULFONAMIDES; TAMOXIFEN; TUMOR CELLS, CULTURED;

EID: 0030781776     PISSN: 10152008     EISSN: 14230291     Source Type: Journal    
DOI: 10.1159/000164120     Document Type: Article

References (42)

1. Furr BJA, Jordan VC: The pharmacology and clinical uses of tamoxifen. Pharmacol Ther 1984;25:127-205.
2. Gallo MA, Kaufman DG: Antagonistic and agonistic effects of tamoxifen: Significance in human cancer. Semin Oncol 1997;24(suppl 1): S1-71-S1-80.
3. Deligdisch L: Effects of hormone therapy on the endometrium. Mod Pathol 1993;6:94-106.
4. Daniel Y, Inbar M, Bar-Ant A, Peyser MR. Lessing JB: The effects of tamoxifen treatment on the endometrium. Fertil Steril 1996:65: 1083-1089.
5. Goldberg K: Tamoxifen is linked to uterine cancer risk in breast cancer patients, studies find; NCI advises informed consent form changes. Clin Cancer Lett 1994;17:1-10.
6. Lc Bouedec G. Dauplat J: Cancer of the endometrium caused by antiestrogens. Rev Fr Gynecol Obstet 1992;87:345-348.
7. O’Neill E. Rodriguez-Mojica W: Asymptomatic carcinoma of the endometrium in a patient on adjunctive tamoxifen therapy for carcinoma of the breast. Bol Asoc Med P R 1992:84:74-77.
8. Horn DW. Vollmer G. von Angerer E, Schneider MR: Effect of the nonsteroidal antiestrogen ZK 119.010 on growth and metastasis of the EnDA endometrial carcinoma. Int J Cancer 1994;58:426-429.
9. Krasilnikov MA, Shatskaya VA. Kuzmina ZV, Barinov VV: Regulation of phospholipid turnover by steroid hormones in endometrial carcinoma and breast cancer cells. Acta Endocrinol 1993;128:543-548.
10. Bissel MJ, Hall HG, Parry GJ: How docs the extracellular matrix direct gene expression? J Thcor Biol 1982;99:31-68.
11. Schreiner C, Fisher M, Hussein S, Juliano RL: Increased tumorigenicity of fibronectin receptor deficient Chinese hamster ovary cell variants. Cancer Res 1991:51:1738-1740.
12. O'Brian CA. Liskamp R, Soloman DH. Weinstein IB: Inhibition of protein kinase C by tamoxifen. Cancer Res 1985;45:2462-2465.
13. Adcrem A: Signal transduction and the actin cytoskeleton: The roles of MARCKS and pro-filin. Trends BiochemSci 1992:17:438-443.
14. Resau JH, Elligct KE. Cottrell JR. Hudson EA: Cell injury and regeneration of human epithelial cells in organ culture. Cell Biol Toxicol 1987:3:441-458.
15. Siegfried JM, Nelson KG, Martin JL, Kaufman DG: Histochemical identification of cultured cells from human endometrium. In Vitro 1984; 20:25-32.
16. Way DL, Grosso DS, Davis JR, Surwit EA, Christian CD: Characterization of a new endometrial carcinoma (RL95-2) established in cell culture. In Vitro 1983:147-158.
17. Kiley SC. Parker PJ, Fabbio R. Jakcn S: Selective redistribution of protein kinase C isozymes by thapsigarin and staurosporine. Carcinogenesis 1992;13:1997-2001.
18. Leahy JC. Vallano ML: Differential effects of isoquiolinesulfonamide protein kinase inhibitors on CAI hippocampal slices. Neuroscience 1991.44:361-370.
19. Carter CA. Rinehart CA, Bagnell CR. Kaufman DG: Fluorescent laser scanning microscopy of F-actin disruption in human endometrial stromal cells expressing the SV40 large T antigen and the EJ ras oncogene. Pathobiology 1991:59:36-45.
20. Polzar B. Nowak E. Goody BS. Mannhcrz HG: The complex of actin and deoxyribonuclease 1 as a model system to study the interactions of nucleotides, cations and cytochalasin D with monomeric actin. Eur J Biochem 1989:192: 267-275.
21. Shuman H. Murray JM. Di Lullo C: Confocal microscopy: An overview. Biotechniques 1989; 7:154-163.
22. Heimer BV, Taylor CED: Improved mountant for immunofluorescent preparations. J Clin Pathol 1974;27:254-256.
23. Carter CA, Progribny M, Davidson A, Jackson CD, McGarrity LJ, Morris SM: Effects of retinoic acid on cell differentiation and reversion toward normal in human endometrial adenocarcinoma (RL95-2) cells. Anticancer Res 1996;16:17-24.
24. Prckeris R, Mayhew MW, White MK, Hernandez RM. Terrian DM: Molecular effects of the interaction between protein kinase C-epsilon and actin. Mol Biol Cell 1996;7:234a.
25. Spangenburg P. Till U, Gschmeissner S, Crawford N: Changes in the distribution and organization of platelet actin induced by diamide and its functional consequences. Br J Haematol 1987;67:433-450.
26. Getzcnbcrg RH, Pienta KJ, Huang EYW. Murphy BC, Coffey DS: Modifications of the intermediate filament and nuclear matrix networks by the extracellular matrix. Biochem Biophys ResCommun 1991;179:340-344.
27. Getzenberg RH, Coffey DS: Tissue specificity of the hormonal response in sex accessory tissues is associated with nuclear matrix protein patterns. Mol Endocrinol 1990;4:1336-1342.
28. Tamkun JW, DiSimone DW. Fonda D, Patel BS, Buck C, Horwitz AF, Hynes RO: Structure of integrins. a glycoprotein involved in transmembrane linkage between fibronectin and actin. Cell 1986:46:271-282.
29. Hynes RO: Integrins: A family of cell surface receptors. Cell 1987;48:549-554.
30. Lawler J, Weinstein R. Hynes RO: Cell attachment to thrombospondin: The role of ARG-GLY-ASP. calcium, and integrin receptors. J Cell Biol 1988;107:2351-2361.
31. Reichardl LF. Tomaselli KJ: Extracellular matrix molecules and their receptors: Functions in neural development. Annu Rev Neurosci 1991; 14:531-570.
32. Marchiso PC; Canccdda R. De Luca M: Structural and functional studies of integrin receptors in cultured human keratinocytes. Cell Differ Dev 1990;32:355-359.
33. Juliano RL. Haskill S: Signal transduction from the extracellular matrix. J Cell Biol 1993; 123: 577-585.
34. Ruck P. Marzusch K, Kaiserling EJ, Homy HP, Dietl J, Geiselhart A, Handgretinger R, Redman CW: Distribution of cell adhesion molecules in decidua of early human pregnancy. An immunohistochcmical study. Lab Invest 1994;71:94-101.
35. Carter CA. Albright CD. Kaufman DG: Differential effects of dioctanoylglycerol on fibronectin localization in normal, partially transformed and malignant cells. Exp Cell Res 1992; 201:262-272.
36. Horfcelt DV, Parmley TH, Roberts DK, Walker NJ: Stromal-epithelial communication in hyperplastic human endometrium. Am J Ob-stet Gynecol 1994;170:1061-1070.
37. Plantefaber LC, Hynes RO: Changes in integrin receptors on oncogenically transformed cells. Cell 1989;56:281-290.
38. Robbins SL, Cotran RS, Kumar V: Pathologic Basis of Disease. Philadelphia, Saunders, 1984, pp 1109-1164.
39. Albright CD, Kaufman DG: Transforming growth factor-pi mediates communication between human endometrial carcinoma cells and stromal cells. Pathobiology 1995;63:314-319.
40. Albright CD, Tsongalis GJ, Resau JH, Kaufman DG: Human endometrial carcinoma cells release factors which inhibit the growth of normal epithelial cells in culture. Cell Biol Toxicol 1995:11:251-261.
41. Cunha GR, Chung LWK, Shannon JM, Tagu-chi D, Fujii H: Hormone-induced morphogenesis and growth: Role of mesenchymal-epithelial interactions. Recent Prog Horm Res 1983; 39:559-598.
42. Kaufman DG, Rinehart CA, Albright CD: Structure and growth regulation in normal, transformed and malignant human endometrial cell cultures; in Rhim JS, Dritschillo A (eds): Neoplastic Transformation in Human Cell Culture. Totawa, Humana Press, 1991, pp 367-376.